We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$96.1B
1-Year Est. Return
40.06%
This Fund
S&P 500
This Quarter
Est. Return
+17.51%
1 Year Est. Return
+40.06%
3 Year Est. Return
+122.14%
5 Year Est. Return
+169.19%
10 Year Est. Return
+659.21%
AUM
$100B
AUM Growth
+$10.6B
(+12%)
Cap. Flow
-$8.63B
Cap. Flow
% of AUM
-8.59%
Top 10 Holdings %
Top 10 Hldgs %
26.3%
Holding
2,775
New
155
Increased
1,258
Reduced
1,081
Closed
127
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$904M |
| 2 |
Boston Scientific
BSX
|
+$485M |
| 3 |
Caterpillar
CAT
|
+$333M |
| 4 |
Cisco
CSCO
|
+$324M |
| 5 |
Walt Disney
DIS
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$494M |
| 2 |
Palantir
PLTR
|
+$281M |
| 3 |
Apple
AAPL
|
+$253M |
| 4 |
Cadence Design Systems
CDNS
|
+$249M |
| 5 |
CrowdStrike
CRWD
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.8% |
| 2 | Financials | 9.83% |
| 3 | Consumer Discretionary | 8.14% |
| 4 | Healthcare | 8.11% |
| 5 | Industrials | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Rimini Street
RMNI
$449M
| $59.6K | ﹤0.01% |
15,796
| – | – |
|
2477
United States Antimony
UAMY
$975M
| $59.5K | ﹤0.01% |
+25,475
| New | +$72.2K |
|
2478
Corvus Pharmaceuticals
CRVS
$1.24B
| $59.1K | ﹤0.01% |
+14,774
| New | +$53.8K |
|
2479
Kaltura
KLTR
$249M
| $59K | ﹤0.01% |
29,375
+961
| +3% | +$1.99K |
|
2480
ADC Therapeutics
ADCT
$150M
| $58.7K | ﹤0.01% |
21,911
-362
| -2% | -$761 |
|
2481
Monte Rosa Therapeutics
GLUE
$1.34B
| $58.4K | ﹤0.01% |
12,958
+1,345
| +12% | +$6K |
|
2482
Aldeyra Therapeutics
ALDX
$91.1M
| $58.3K | ﹤0.01% |
15,226
+1,302
| +9% | +$3.37K |
|
|
WOW
2483
DELISTED
WideOpenWest
WOW
| $57.4K | ﹤0.01% |
14,143
| – | – |
|
|
OLPX
2484
DELISTED
Olaplex Holdings
OLPX
| $57K | ﹤0.01% |
40,689
+2,669
| +7% | +$3.48K |
|
2485
Perspective Therapeutics
CATX
$363M
| $56.9K | ﹤0.01% |
16,546
+1,129
| +7% | +$2.98K |
|
2486
Codexis
CDXS
$159M
| $56.4K | ﹤0.01% |
23,124
+1,225
| +6% | +$2.87K |
|
2487
Cardiff Oncology
CRDF
$81.7M
| $56.3K | ﹤0.01% |
17,885
+1,781
| +11% | +$5.43K |
|
|
LPRO
2488
DELISTED
Open Lending Corp
LPRO
| $56.3K | ﹤0.01% |
29,031
| – | – |
|
|
ESPR
2489
DELISTED
Esperion Therapeutics
ESPR
| $55.7K | ﹤0.01% |
56,580
+3,814
| +7% | +$3.82K |
|
2490
Candel Therapeutics
CADL
$780M
| $55.6K | ﹤0.01% |
+10,981
| New | +$56.5K |
|
2491
3D Systems Corp
DDD
$633M
| $55.5K | ﹤0.01% |
36,061
| – | – |
|
2492
Rocket Pharmaceuticals
RCKT
$384M
| $55.1K | ﹤0.01% |
22,508
+3,151
| +16% | +$16K |
|
2493
Arq
ARQ
$99.1M
| $55K | ﹤0.01% |
+10,249
| New | +$44.9K |
|
2494
Editas Medicine
EDIT
$453M
| $55K | ﹤0.01% |
25,003
+457
| +2% | +$748 |
|
2495
Getty Images
GETY
$121M
| $54.8K | ﹤0.01% |
32,985
+5,030
| +18% | +$8.87K |
|
2496
Sight Sciences
SGHT
$427M
| $54.7K | ﹤0.01% |
13,248
+2,831
| +27% | +$9.45K |
|
2497
Vuzix
VUZI
$220M
| $54K | ﹤0.01% |
+18,476
| New | +$43.6K |
|
2498
OmniAb
OABI
$491M
| $53.2K | ﹤0.01% |
30,572
+2,809
| +10% | +$4.7K |
|
2499
Verastem
VSTM
$638M
| $52.9K | ﹤0.01% |
12,758
+2,180
| +21% | +$13.7K |
|
2500
Definitive Healthcare
DH
$68.7M
| $52.8K | ﹤0.01% |
13,542
-1,201
| -8% | -$3.78K |
|
Similar funds
VOYA Investment Management's Q2 2025 Portfolio in Review
As of Q2 2025, VOYA Investment Management held 2,775 positions worth $100B, up 12% from $89.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
VOYA Investment Management withdrew a net $8.63B in Q2 2025, closing 127 positions and reducing 1,081 holdings. Its most notable exit was Discover Financial Services, an estimated $241M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, VOYA Investment Management opened a new position in Shift4 Payments Inc 6.00% Series A Preferred Stock worth $80.6M.
- VOYA Investment Management's largest Q2 2025 buy was Shift4 Payments Inc 6.00% Series A Preferred Stock: 700,000 shares worth $80.6M.
- VOYA Investment Management added most to Microsoft in Q2 2025, an estimated $904M increase.
- VOYA Investment Management's biggest Q2 2025 reduction was Salesforce, cutting an estimated $494M.
- VOYA Investment Management fully exited Discover Financial Services in Q2 2025, selling an estimated $241M.
- VOYA Investment Management's ten largest holdings make up 26% of its $100B portfolio in Q2 2025.
- VOYA Investment Management opened 155 new positions and closed 127 in Q2 2025.
- VOYA Investment Management's portfolio value rose 12% quarter-over-quarter to $100B.
Based on VOYA Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.